Clinical Trials Browser

Phase 1 × Unknown × Solid Tumor, Adult × Clear all

NCT05763004 2024-10-08

A Clinical Study to Evaluate the Safety, Tolerability and Efficacy of IOS-1002 Administered Alone and in Combination with Pembrolizumab, a PD-1 Monoclonal Antibody in Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor, Adult

NCT06240767 2024-02-05

Clinical Study on the Treatment of Advanced Recurrent Tumors With Anticancer Mouse Characteristic Human Neutrophils

Phase 1 Unknown

Other solid neoplasm

Solid Tumor, Adult

NCT06232863 2024-02-02

A Study of BH009 in Head and Neck Squamous Cell Carcinoma and Ovarian Cancer

Phase 1 Unknown

Other solid neoplasm

Solid Tumor, Adult

NCT05388487 2024-01-16

Tolerability and Safety of HF1K16 Injection in Patients With Refractory Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor, Adult

NCT04976218 2022-11-16

TGFβR-KO CAR-EGFR T Cells in Previously Treated Advanced EGFR-positive Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor, Adult

NCT05060263 2021-09-29

A Study of of HOT1030 in Patients With Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor, Adult

NCT03398720 2018-01-12

Safety and Tolerability of HTI-1066 in Subjects With Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor, Adult